Chicago Board of Trade › 30 DAY FED FUND May 2013 (E) (CBOT:ZQ.K13.E)
99.8875 +0.0025 (0.00%)
2013-05-24 07:48:21, 10 min delay
| Last Price | 99.8875 |
|---|---|
| Settle Time | 17:15 |
| Previous Close | 99.8875 |
| Low | 99.8875 |
| Open Int. | 47691 |
| Contract High | 99.92 |
| Contract Low | 97.855 |
| First Delivery | 2013-06-14 |
| Open Time | 18:00 |
| Net Change | 0.0025 |
|---|---|
| Open | 99.8875 |
| High | 99.8875 |
| Volume | 635 |
| Time | 2013-05-24 07:48:21 |
| Contract High Date | 2011-09-21 |
| Contract Low Date | 2011-04-06 |
| Expiration | 2013-05-31 |
| Close Time | 17:00 |
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money.
Trader's Blog
Weekly Futures Recap W/Mike Seery
5 hours ago
Today's Video Update: If The Economy Is So Good, Why Did This Happen?
7 hours ago
Sell In May And Go Away
11 hours ago
Chart to Watch - EURGBP
12 hours ago
Today's News
Valeant shares jump on Bausch & Lomb deal rumor
4 hours ago
Shares of Valeant Pharmaceuticals International Inc. spiked up Friday afternoon after a report said it might soon buy eye care company Bausch & Lomb Inc. Both comments wouldn't comment. That's about 2 1/2 times the 2012 revenue reported by Valeant, which specializes in dermatology medicines. It also sells a range of brand-name and generic drugs, as well as nonprescription medicines.
NBC to air Blake Shelton's benefit for Oklahomans
5 hours ago
NBC and sister networks will air Blake Shelton's concert to help his fellow Oklahomans affected by this week's storms in their home state. Joining Shelton in performing will be Grammy Award-winning artists Miranda Lambert, Reba and Vince Gill. Additional guests will be announced shortly, NBC said Friday. The concert will originate from Chesapeake Energy Arena in Oklahoma City.
Correction: Sequenom-Mover story
5 hours ago
In a story May 13 about Sequenom Inc., The Associated Press erroneously reported that Sequenom's MaterniT21 test was cleared by the Food and Drug Administration before its launch in 2011. Diagnostic tests that are made and sold by a single lab, as MaterniT21 is, aren't required to be approved by the FDA.
AP Top Financial News At 4:18 p.m. EDT
4 hours ago
Summer travel forecast: Better, but no blowout Stocks fade, post first weekly loss in a month US durable goods orders rise 3.3 percent in April
